Form 8-K - Current report:
SEC Accession No. 0001144204-15-012417
Filing Date
2015-02-27
Accepted
2015-02-27 09:00:18
Documents
3
Period of Report
2015-02-27
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v402957_8-k.htm 8-K 14427
2 EXHIBIT 99.1 v402957_ex99-1.htm EX-99.1 10296
3 GRAPHIC logo.jpg GRAPHIC 8460
  Complete submission text file 0001144204-15-012417.txt   37689
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36357 | Film No.: 15655122
SIC: 2834 Pharmaceutical Preparations